Our Mission

Unlocking the power of biologics

Developing selective tolerogenic therapies and restoring self-tolerance in autoimmune diseases.

Our Purpose

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity with our pioneering ImmTOR™ immune tolerance platform.

Our Platform

ImmTORTM Selective Immune Tolerance Technology

Our clinically validated ImmTOR™ platform allows us to develop tolerogenic therapies that selectively mitigate unwanted immune responses. Investigate immunogenicity & the potential of ImmTOR.

Portfolio

Leveraging our ImmTOR™ platform to amplify the efficacy of biologic therapies

The broad applicability of the ImmTOR platform gives us the unique ability to address immunogenicity across indications, including enabling redosing of life saving gene therapies and restoring self-tolerance in autoimmune diseases.

About Us

Developing selective tolerogenic therapies

We are an experienced and diverse team of scientists, physicians, entrepreneurs and biotech experts all working towards the goal of unlocking the full potential of biologic therapies and restoring self-tolerance in autoimmune diseases.

Join our Team

Selecta Biosciences is poised to transform cutting-edge biologic treatments for other serious and debilitating diseases.